Compare
Oaktree Acquisition Corp. III Life Sciences vs Dynamix Corp III vs Vendome Acquisition Corp I vs Pyrophyte Acquisition Corp. II
| Latest fiscal year | Oaktree Acquisition Corp. III Life Sciences OACC | Dynamix Corp III DNMX | Vendome Acquisition Corp I VNME | Pyrophyte Acquisition Corp. II PAII |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | n/a | n/a | n/a |
| Revenue growth (YoY) | n/a | n/a | n/a | n/a |
| Gross margin | n/a | n/a | n/a | n/a |
| Operating margin | n/a | n/a | n/a | n/a |
| Net margin | n/a | n/a | n/a | n/a |
| Net income | $7.29M | n/a | n/a | n/a |
| EPS (Diluted) | n/a | n/a | n/a | n/a |
| Operating cash flow | -$422.1K | n/a | n/a | n/a |
| Free cash flow | n/a | n/a | n/a | n/a |
| Cash & equivalents | $1.43M | $1.33M | n/a | n/a |
| Total assets | $203.11M | $203.94M | $204.61M | $204.80M |
| Total liabilities | $8.32M | $8.30M | n/a | $9.46M |
| Shareholders' equity | -$6.77M | -$6.83M | $404.7K | -$8.67M |
| Return on year-end equity | n/a | n/a | n/a | n/a |
| Shares outstanding | n/a | n/a | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Oaktree Acquisition Corp. III Life Sciences | Dynamix Corp III | Vendome Acquisition Corp I | Pyrophyte Acquisition Corp. II |
|---|---|---|---|---|
| Latest | n/a | n/a | n/a | n/a |
| 1 year earlier | n/a | n/a | n/a | n/a |
| 2 years earlier | n/a | n/a | n/a | n/a |
| 3 years earlier | n/a | n/a | n/a | n/a |
| 4 years earlier | n/a | n/a | n/a | n/a |